{{Rsnum
|rsid=17410015
|Gene=LOC100506029
|Chromosome=1
|position=101086370
|Orientation=plus
|GMAF=0.04362
|Gene_s=PLA2G2D
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 16.8 | 82.3
| HCB | 0.0 | 8.0 | 92.0
| JPT | 0.0 | 2.7 | 97.3
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 1.8 | 98.2
| CHB | 0.0 | 8.0 | 92.0
| CHD | 0.0 | 2.8 | 97.2
| GIH | 0.0 | 1.0 | 99.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 6.9 | 93.1
| MKK | 0.0 | 0.6 | 99.4
| TSI | 0.0 | 13.7 | 86.3
| HapMapRevision=28
}}{{PMID|20195266|OA=1
}} gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 2 x 10^-6 for triglycerides as a result of [[perphenazine]] use

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}